SCHEMBL1709045

SCHEMBL1709045

CC(C)(C)OC(=O)NC(c1ccc(Cl)cc1)[C@H](c1ccc(Cl)cc1)[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.41
PPARG P37231 2/20 0.40
PPARA Q07869 2/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
S1PR3 Q99500 2/20 0.39
GAA P10253 2/20 0.38
P2RY2 P41231 1/20 0.38
CACNA1B Q00975 1/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
BCL2 P10415 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
CNR1 P21554 3/20 0.35
CNR2 P34972 2/20 0.35
AAK1 Q2M2I8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699000 1.00 TRPA1 (0.41) TRPA1PPARGPPARAALDH1A1MAPT
SCHEMBL1708913 1.00 TRPA1 (0.41) TRPA1PPARGPPARAALDH1A1MAPT
SCHEMBL17301886 0.94 AAK1 (0.41) TRPA1PPARGPPARAALDH1A1MAPT
SCHEMBL17302203 0.94 AAK1 (0.41) TRPA1PPARGPPARAALDH1A1MAPT
SCHEMBL17302049 0.94 AAK1 (0.41) TRPA1PPARGPPARAALDH1A1MAPT
SCHEMBL17302201 0.94 AAK1 (0.41) TRPA1PPARGPPARAALDH1A1MAPT
SCHEMBL17302054 0.90 S1PR3 (0.46) TRPA1PPARGPPARAALDH1A1MAPT
SCHEMBL17302048 0.87 S1PR3 (0.43) TRPA1PPARGALDH1A1MAPTS1PR3
SCHEMBL17302055 0.86 S1PR3 (0.41) ALDH1A1MAPTS1PR3CACNA1BLMNA
SCHEMBL17302064 0.84 S1PR3 (0.41) PPARGS1PR3LMNACNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088915-A1 STEREOSELECTIVE METHODS, CATALYSTS AND INTERMEDIATES FOR THE SYNTHESIS OF (-)-NUTLIN-3 AND RELATED COMPOUNDS VANDERBILT UNIVERSITY 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088915-A1 STEREOSELECTIVE METHODS, CATALYSTS AND INTERMEDIATES FOR THE SYNTHESIS OF (-)-NUTLIN-3 AND RELATED COMPOUNDS NUTF2, MDM2, CIAPIN1 TRPA1 2961/4885PPARG 3695/4885PPARA 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.